Speaker illustration

Professor Natasja de Groot

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

Member of:

European Heart Rythm Association

Prof. Dr. Natasja MS de Groot works as cardiologist-electrophysiologist at the Erasmus Medical Center, Rotterdam, the Netherlands; she is full professor in electrophysiology at the Erasmus Medical Center and Delft Technical University. She is co-founder of the Atrial Fibrillation Innovation Platform, a foundation aimed at co-creating research projects together with patients and leader of the Medical Delta Cardiac Arrhythmia Lab. She is Fellow of the EHRA and is involved in writing various international guidelines. Her expertise include catheter ablation of arrhythmias/device therapy in adult and pediatric patients with congenital heart disease and high resolution mapping to unravel arrhythmia mechanisms, innovation in diagnosis and therapy of cardiac arrythmias and signal recording and processing technologies.

Virtual reality: the gateway to precision cardiovascular medicine

Event: ESC Congress 2022

Topic: e-Cardiology/Digital Health

Session type: Symposium

Thumbnail

Arrhythmia in congenital heart disease: inevitable but not untreatable!

Event: ESC Congress 2022

Topic: Congenital Heart Disease and Paediatric Cardiology

Session type: Moderated ePosters

Thumbnail

Sudden cardiac death in adult congenital heart disease (ACHD)

Event: ESC Congress 2021 - The Digital Experience

Topic: Congenital Heart Disease and Paediatric Cardiology

Session type: Symposium

Thumbnail

Prognosis, identification & treatment of ventricular arrhythmia

Event: ESC CONGRESS 2019

Topic: Treatment

Session type: Rapid Fire Abstracts

Thumbnail

Digital cardiovascular health solutions

Event: ESC CONGRESS 2019

Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support

Session type: Symposium

Thumbnail

Insight into atrial physiology and pathology

Event: ESC CONGRESS 2019

Topic: Arrhythmias

Session type: Moderated Posters

Thumbnail

Atrial fibrillation ablation: stroke and bleeding

Event: ESC Congress 2018

Topic: Pathophysiology and Mechanisms

Session type: Symposium

Thumbnail

Outcomes in atrial fibrillation: room for improvement?

Event: ESC CONGRESS 2017

Topic: Primary cardiovascular prevention: interventions and outcomes

Session type: Moderated Posters

Thumbnail

Progress in stroke prevention in atrial fibrillation

Event: ESC CONGRESS 2017

Topic: Atrial fibrillation (AF)

Session type: Moderated Posters

Thumbnail

Cancer therapy and arrhythmias

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Pharmacology

Session type: Symposium

Thumbnail

This platform is supported by

logo Novo Nordisk